| Trial ID: | L0731 |
| Source ID: | ChiCTR1900025787
|
| Associated Drug: |
Growth Hormone
|
| Title: |
Efficacy of growth hormone on liver metabolic function for the secondary non-alcoholic fatty liver disease in patients with pituitary stalk interruption syndrome:A prospective, open-label, randomized, parallel controlled clinical trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
the secondary non-alcoholic fatty liver disease in adults with pituitary stalk interruption syndrome
|
| Interventions: |
GH treatment group:GH 1u/d for male,1.5u/d for female;vitamin E treatment group:vitamin E 800u/d P.O.;lifestyle modification group:healthy diet,weight loss, regular exercise;
|
| Outcome Measures: |
controlled attenuation parameter;liver stiffiness measurement;triglyceride;cholesterol;high-density lipoprotein;low density lipoprotein;glutamic-pyruvic transaminase;
|
| Sponsor/Collaborators: |
Peking Union Medical College Hospital
|
| Gender: |
All
|
| Age: |
nannan
|
| Phases: |
Not applicable
|
| Enrollment: |
GH treatment group:25;vitamin E treatment group:25;lifestyle modification group:25;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
08/09/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
9 September 2019
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=42334
|
